Nontypeable Haemophilus influenzae P5 Binds Human C4b-Binding Protein, Promoting Serum Resistance

dc.contributor.authorThofte, Oskar
dc.contributor.authorBettoni, Serena
dc.contributor.authorSu, Yu Ching
dc.contributor.authorThegerström, John
dc.contributor.authorJonsson, Sandra
dc.contributor.authorMattsson, Emma
dc.contributor.authorSandblad, Linda
dc.contributor.authorMartí Martí, Sara
dc.contributor.authorGarmendia, Junkal
dc.contributor.authorBlom, Anna M.
dc.contributor.authorRiesbeck, Kristian
dc.date.accessioned2022-01-27T16:39:05Z
dc.date.available2022-01-27T16:39:05Z
dc.date.issued2021-08-25
dc.date.updated2022-01-25T14:06:06Z
dc.description.abstractNontypeable Haemophilus influenzae (NTHi) is a Gram-negative human pathogen that causes infections mainly in the upper and lower respiratory tract. The bacterium is associated with bronchitis and exacerbations in patients suffering from chronic obstructive pulmonary disease and frequently causes acute otitis media in preschool children. We have previously demonstrated that the binding of C4b binding protein (C4BP) is important for NTHi complement evasion. In this study, we identified outer membrane protein 5 (P5) of NTHi as a novel ligand of C4BP. Importantly, we observed significantly lower C4BP binding and decreased serum resistance in P5-deficient NTHi mutants. Surface expression of recombinant P5 on Escherichia coli conferred C4BP binding and consequently increased serum resistance. Moreover, P5 expression was positively correlated with C4BP binding in a series of clinical isolates. We revealed higher levels of P5 surface expression and consequently more C4BP binding in isolates from the lower respiratory tract of chronic obstructive pulmonary disease patients and tonsil specimens compared with isolates from the upper respiratory tract and the bloodstream (invasive strains). Our results highlight P5 as an important protein for protecting NTHi against complement-mediated killing.
dc.format.extent13 p.
dc.format.mimetypeapplication/pdf
dc.identifier.issn1550-6606
dc.identifier.pmid34433620
dc.identifier.urihttps://hdl.handle.net/2445/182733
dc.language.isoeng
dc.publisherThe American Association of Immunologists
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.4049/jimmunol.2100105
dc.relation.ispartofThe Journal of Immunology, 2021, vol 207, num 6, p. 1566-1577
dc.relation.urihttps://doi.org/10.4049/jimmunol.2100105
dc.rightscc by (c) Thofte, Oskar et al, 2021
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.sourceArticles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))
dc.subject.classificationBacils
dc.subject.classificationBacteris patògens
dc.subject.classificationProteïnes
dc.subject.otherBacillus (Bacteria)
dc.subject.otherPathogenic bacteria
dc.subject.otherProteins
dc.titleNontypeable Haemophilus influenzae P5 Binds Human C4b-Binding Protein, Promoting Serum Resistance
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
1566.full.pdf
Mida:
2.39 MB
Format:
Adobe Portable Document Format